---
title: "Prosthetics Industry: Companies, KPIs"
description: "16 SEC filers are classified under the Standard Industrial Classification code that describes the prosthetics industry."
canonical: https://www.getswoopr.com/stocks/industries/health-care/prosthetics/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Prosthetics Industry

## Direct Answer

16 SEC filers are classified under the Standard Industrial Classification code that describes the prosthetics industry, and their latest annual reports show $37.5 billion of combined revenue and a median operating margin of -0.5%. Investors should still evaluate its revenue model, industry-specific KPIs, valuation framework and the risks that can change the group's economics.

## Industry Overview

Prosthetics companies design and fit artificial limbs and orthotic devices, often through patient care clinics, paid by insurers. Technology such as microprocessor joints raises prices, and coverage rules shape adoption. The first numbers to compare across companies here are patients treated, revenue per patient and device and clinic revenue.

## Key Industry Metrics

- **Patients treated**: Number of patients fitted at clinics. It is the base volume measure, and follows referrals and population needs.
- **Revenue per patient**: Average payment per patient, including devices and fitting. Advanced microprocessor devices raise it, subject to coverage.
- **Device and clinic revenue**: Split between device manufacturing sales and patient care service income. Mix shows how integrated the business is and where margins come from.
- **Reimbursement rates**: Payment levels from insurers and government for devices and care. Limits on coverage restrict device choice and pricing.
- **Gross margin**: Share of revenue left after device and clinical cost. Advanced devices and efficient fitting support it.

## Primary Macro Drivers

- **Amputee population and diabetes**: More amputations from diabetes and vascular disease raise the number of patients needing devices, which supports patients treated.
- **Insurance coverage**: Insurers decide how much they pay for limbs and advanced components, which sets revenue per patient and mix.
- **Technology advances**: Microprocessor-controlled joints and powered devices lift price per patient and demand from active users, which supports revenue per patient.
- **Clinic expansion**: Owning patient clinics provides direct access to patients and recurring fitting revenue, which supports device and clinic revenue.

## Major Risks

- **Reimbursement limits**: Coverage limits on advanced components reduce what patients can get, lowering revenue per patient; watch reimbursement rate changes.
- **Small patient populations**: The patient base is small, so growth depends on a narrow group; watch patients treated and clinic count.
- **Competition**: Rivals offer devices at lower cost or with new features, pressuring price and share; watch gross margin and product launches.
- **Regulatory audits**: Payer audits of documentation and medical need can lead to repayments; watch legal notes and cash collection.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | Medium |
| Industry Maturity | Mature |
| Geographic Importance | U.S. / Global |

## Prosthetics Filers in the SEC Record

16 companies with annual reports in the dataset are classified by the SEC in the Standard Industrial Classification code 3842. Their latest fiscal years end between 2025 and 2026, and together they reported $37.5 billion of revenue. Median revenue growth over the prior year was 7.2%. Median operating margin was -0.5% and median net margin 7.9%. Median total liabilities were 42% of total assets, and 10 of 16 reported a profit in their latest year.

| Company | Revenue | Growth | Operating margin | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Intuitive Surgical Inc](https://www.getswoopr.com/stocks/companies/intuitive-surgical/) | $10.1 billion | 20.5% | 29.3% | 28.4% | FY 2025 |
| [Zimmer Biomet Holdings, Inc.](https://www.getswoopr.com/stocks/companies/zimmer-biomet/) | $8.2 billion | 7.2% | 13.3% | 8.6% | FY 2025 |
| [Edwards Lifesciences Corp](https://www.getswoopr.com/stocks/companies/edwards-lifesciences/) | $6.1 billion | 11.5% | 20.8% | 17.7% | FY 2025 |
| [Steris Plc](https://www.getswoopr.com/stocks/companies/steris/) | $5.9 billion | 8.7% | 18.6% | 13.2% | FY 2026 |
| [Align Technology Inc](https://www.getswoopr.com/stocks/companies/align-technology/) | $4.0 billion | 0.9% | 13.5% | 10.2% | FY 2025 |
| [Msa Safety Inc](https://www.getswoopr.com/stocks/companies/msa-safety-incorporated/) | $1.9 billion | 3.7% | 19.8% | 14.9% | FY 2025 |
| [Cadre Holdings, Inc.](https://www.getswoopr.com/stocks/companies/cadre-holdings-inc/) | $610 million | 7.5% | 11.0% | 7.2% | FY 2025 |
| [Inogen Inc](https://www.getswoopr.com/stocks/companies/inogen-inc/) | $349 million | 3.9% | -8.7% | 6.5% | FY 2025 |

The 8 largest of 16 by revenue. Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. A company's SIC code reflects its main business as the SEC records it, so it can differ from how an index provider or analyst classifies the company, and a diversified group appears under only one code.

## Where to Go Next

The Prosthetics guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Health Care

- [Health Care sector overview](https://www.getswoopr.com/stocks/industries/health-care/)
- [Proteomics](https://www.getswoopr.com/stocks/industries/health-care/proteomics/)
- [Primary Care Platforms](https://www.getswoopr.com/stocks/industries/health-care/primary-care-platforms/)
- [Rare Disease Biotechnology](https://www.getswoopr.com/stocks/industries/health-care/rare-disease-biotechnology/)
- [Physician Practice Management](https://www.getswoopr.com/stocks/industries/health-care/physician-practice-management/)
- [Rare Disease Pharmaceuticals](https://www.getswoopr.com/stocks/industries/health-care/rare-disease-pharmaceuticals/)
- [Pharmacy Benefit Managers](https://www.getswoopr.com/stocks/industries/health-care/pharmacy-benefit-managers/)
- [Regenerative Medicine](https://www.getswoopr.com/stocks/industries/health-care/regenerative-medicine/)
- [Pharmacy & Benefit Services](https://www.getswoopr.com/stocks/industries/health-care/pharmacy-and-benefit-services/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Prosthetics industry?

Key performance indicators for the Prosthetics industry include: Patients treated, Revenue per patient, Device and clinic revenue, Reimbursement rates, Gross margin. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Prosthetics industry?

The Prosthetics industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.

What are the biggest risks in the Prosthetics industry?

The primary risks for Prosthetics companies include: Reimbursement limits, Small patient populations, Competition, Regulatory audits. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).
